Cost-effectiveness of mepolizumab for severe eosinophilic asthma in China.
Chaogang X, Mengna A, Zhen W, Ying L, Xin G, Xin Z, Shengjie Z, Yuan Z, Qian L, Wenbin M, Weiyi F.
Chaogang X, et al. Among authors: xin g, xin z.
J Asthma. 2024 Mar 12:1-8. doi: 10.1080/02770903.2024.2324855. Online ahead of print.
J Asthma. 2024.
PMID: 38470879